Copyright
©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Diabetes. Mar 15, 2023; 14(3): 290-298
Published online Mar 15, 2023. doi: 10.4239/wjd.v14.i3.290
Published online Mar 15, 2023. doi: 10.4239/wjd.v14.i3.290
Prevalence of type 2 diabetes mellitus in the pediatric population of a third-level care hospital in Mexico City in 2013 and 2018
Jorge Mario Molina-Díaz, Department of Child Endocrinology, Children’s Hospital Federico Gomez, Autonomous University of Mexico, Mexico City 06250, Mexico
Blanca Estela Vargas-Terrez, Faculty of Business, La Salle University, Mexico City 06250, Mexico
Patricia Guadalupe Medina-Bravo, Department of Endocrinology, Children’s Hospital Federico Gomez, Mexico City 06720, Mexico
Antonia Martínez-Ambrosio, Department of Nursing and Endocrinology, Children’s Hospital Federico Gómez, Mexico City 06720, Mexico
América Liliana Miranda-Lora, Epidemiological Research Unit in Endocrinology and Nutrition, Children’s Hospital Federico Gomez, Mexico City 06720, Mexico
Miguel Klünder-Klünder, Division of Research, Children’s Hospital Federico Gomez, Mexico City 06720, Mexico
Author contributions: Molina JM and Vargas BE conceptualized and wrote the initial manuscript; Martínez A and Medina PG critically reviewed the manuscript; Miranda AL and Klünder M edited the manuscript; Molina JM finalized the manuscript.
Institutional review board statement: This study was authorized by the ethics and research committee of the Federico Gomez Children's Hospital of Mexico.
Informed consent statement: All study participants, or their legal guardian, provided informed written consent prior to study enrollment.
Conflict-of-interest statement: All the authors declare they have no conflict of interest to disclose.
Data sharing statement: No additional data are available.
STROBE statement: The authors have read the STROBE Statement—checklist of items, and the manuscript was prepared and revised according to the STROBE Statement—checklist of items.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Jorge Mario Molina-Díaz, PhD, Doctor, Department of Child Endocrinology, Children’s Hospital Federico Gomez, Autonomous University of Mexico, Mexico City 06250, Mexico. dereck79@live.com.mx
Received: November 15, 2022
Peer-review started: November 15, 2022
First decision: January 3, 2023
Revised: January 15, 2023
Accepted: February 14, 2023
Article in press: February 14, 2023
Published online: March 15, 2023
Processing time: 120 Days and 14.4 Hours
Peer-review started: November 15, 2022
First decision: January 3, 2023
Revised: January 15, 2023
Accepted: February 14, 2023
Article in press: February 14, 2023
Published online: March 15, 2023
Processing time: 120 Days and 14.4 Hours
Core Tip
Core Tip: Diabetes mellitus was a disease exclusive to the adult population; however, due to an increase in the prevalence of obesity, as well as genetic risk factors, this disease has increased in the pediatric population, having a different presentation, with the presence that causes micro and macrovascular complications at earlier ages. Therefore, it is necessary to think about this disease when faced with data of insulin resistance and identify complications early.